Phil McGurkHead of East Coast Business Development & Acquisitions at AbbVie
Phil is the Head of East Coast Business Development & Acquisitions at AbbVie and joined the company in May 2019. Before joining AbbVie, Phil spent 17 years at Pfizer in their business development group where he has been involved in a multitude of different deal types at all stages of discovery, development and commercialization in multiple therapeutic areas. Most recently, he was the Global Business Development Lead for the Inflammation & Immunology business.
Prior to Pfizer, Phil spent 2 years as the Life Science Technology Transfer lead at the University of Bradford in England.
Phil has a Bachelor’s degree in Chemistry and Business from the University of Abertay Dundee, a Ph.D in Synthetic Organic Chemistry from the University of St. Andrews and an MBA from the University of Bradford.